Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib OLE in Crohn's Disease
NCT01470599Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2012
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 2 trial of tofacitinib oral solution in Crohn's disease, sponsored by Pfizer. Started Apr 2012; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01470599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470599.